Your Messages Inbox
Your Article Summary
See Latest ArticlesInterim report for the second quarter of 2009: Bayer robust in a difficult environment
BayNews International, 08/17/09
In the second quarter of 2009 the Bayer Group's businesses turned in a robust performance in a difficult environment. "The clear increase in sales and earnings at HealthCare was particularly pleasing," Management Board Chairman Werner Wenning commented when the interim report was published on Wednesday. CropScience also continued to increase sales and matched the good earnings level of the prior–year period. MaterialScience improved its performance compared with the first quarter of 2009 but remained well below the prior year. The signs that the bottom of the cycle has been reached in the industrial business have thus been confirmed, although a lasting improvement is not yet in sight.
Today in Financial Reports...keeping you current
Receive free subspecialty "5-minute updates" via email
Genzyme Provides Update on Cerezyme Supply and 2009 Financial Information
Genzyme, 12/07/09
Medtronic Board Approves Third Quarter Cash Dividend for Fiscal Year 2010
Medtronic, 12/04/09
Taro Provides Preliminary Third Quarter and Year-to-Date 2009 Financial Results
Taro Pharmaceuticals USA, 12/03/09
Article Search
Sponsor